QTMeds

TIAPRIDAL 100 mg

Clinical Description (Database Summary)

Tiapride has the potential to block hERG channels (IKr​), but the concentrations required to cause significant inhibition are well above therapeutic plasma concentrations. However, clinical case reports of QT prolongation and Torsades de Pointes have been documented.

Scientific Sources / References

https://doi.org/10.4196/kjpp.2010.14.5.305, https://doi.org/10.1016/s0002-9343(00)00564-7